Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Grassley reasserts S 1002

This article was originally published in The Gray Sheet

Executive Summary

In a June 7 "Dear Colleague" letter, Senate Finance Committee Chair Chuck Grassley (R-Iowa) responds to a recent Republican Policy Committee paper advising against extension of the physician-owned specialty hospital moratorium by emphasizing his "Hospital Fair Competition Act of 2005," which would allow gainsharing arrangements in lieu of physician self-referral (1"The Gray Sheet" May 16, 2005, p. 6). While revision of the DRG payment system has been viewed as a viable solution to anticompetitive practices within the specialty hospital realm, Grassley claims such changes "alone are not enough." S 1002 would "level the playing field to allow for true competition," he says...

You may also be interested in...



Gainsharing Could Gain Momentum Under Senate’s Specialty Hospital Bill

Gainsharing arrangements between hospitals and physicians to foster improved efficiency would be allowed under "The Hospital Fair Competition Act of 2005" (S 1002), introduced May 11

Prestige Expands UK Eye Care Range In Response To Consumer Demand

A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.

Who’s Hired? Hikma Recruits New US Generics President

A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel